misrepresentation

uniQure faces securities class action lawsuit alleging misstatements about Pivotal Study design and FDA approval. Lead plaintiff deadline: April 13, 2026.

Ramaco Resources faces class action securities fraud lawsuit over alleged misrepresentation of Wyoming Brook Mine operations; eligible shareholders must file claims by March 31, 2026.

Rosen Law Firm files securities class action against Ardent Health for alleged misrepresentations in accounts receivable and insurance reserves. March 9 deadline for lead plaintiff claims.

Levi & Korsinsky files class action against Inovio Pharmaceuticals alleging management misrepresented FDA accelerated approval eligibility for lead candidate, causing stock decline.

Rosen Law Firm urges Masonite ($DOOR) investors who sold shares June 2023-February 2024 to join securities class action before April 7, 2026 deadline, alleging undisclosed acquisition information.

uniQure faces securities class action over alleged misrepresentations regarding FDA approval status of Huntington's Disease trial design and regulatory timeline delays. Lead plaintiff deadline April 13, 2026.

CoreWeave investors have until March 13, 2026, to join securities fraud class action alleging misrepresented demand and concealed construction delays that triggered 16% stock decline.

Bleichmar Fonti & Auld files securities fraud class action against Ardent Health after 33% stock plunge following $43M revenue decline disclosure. Deadline March 9.

Plug Power faces securities fraud suit over DOE loan misrepresentations; investors have until April 3, 2026 to join class action after 17% stock decline.

NuScale Power faces securities fraud lawsuit over misrepresentations about ENTRA1 partner capabilities. Stock declined 12.4% after $495 million payment disclosure. Investors have until April 20, 2026 to join class action.

Fermi Inc. stock crashed 33% after tenant terminated $150M funding deal for Project Matador nuclear data center. Investors have until March 6, 2026, to join securities fraud class action.

BellRing Brands faces securities lawsuit alleging misrepresented sales growth. March 23, 2026 deadline for investors with losses exceeding $100,000 to join class action.

UniQure faces securities lawsuit alleging material misrepresentations about its Huntington's Disease trial design and FDA approval status. Lead plaintiff deadline is April 13, 2026.

Fermi Inc. faces securities lawsuit alleging misleading statements about Project Matador AI data center. Stock fell 59% after primary tenant terminated $150M funding agreement.

NuScale Power faces securities lawsuit for allegedly failing to disclose material risks tied to its ENTRA1 partnership, which resulted in a $495 million payment obligation and significant stock decline.

Lakeland Industries faces securities lawsuit over acquisition disclosures, alleging material misrepresentations about Pacific Helmets and Jolly deals. Stock fell 39% after earnings miss.

Law firm Bernstein Liebhard files class action lawsuit against Corcept Therapeutics for alleged material misrepresentations about relacorilant drug clinical evidence.

Bernstein Liebhard files class action lawsuit against Zynex for alleged overbilling scheme artificially inflating revenue from 2018-2023. Affected shareholders urged to evaluate legal options.

Oracle faces a class action lawsuit alleging it failed to disclose financial risks tied to its AI infrastructure investments, citing misaligned capital spending and revenue growth.

Portnoy Law Firm sues Richtech Robotics for falsely claiming Microsoft partnership. Stock fell 29% after Microsoft denied commercial relationship, causing investor losses.